Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. About Eleusis.

Therapy 52

Therapy Research and Development Business Access 52

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. An estimated 4 million to 6 million Americans are on disability because of TBI.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. An estimated 4 million to 6 million Americans are on disability because of TBI.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2013 Sep;36(9):2530-5.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. For the regulated community, this is a trend worth watching. Davis et al.,

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Alchimia

OCTOBER 15, 2021

According to a new study, CBD-infused shampoos , such as Cannabios shampoo and shower gel , “could significantly reduce both the severity and symptoms of scalp inflammation within two weeks, with excellent tolerability and treatment satisfaction with subjects with scalp psoriasis or seborrheic dermatitis”, the researchers concluded.

CBD 59

CBD Sleep Treatment Cannabinoids 59

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). MJA, 16 December 2013). These framings occurred most consistently in Australian Doctor ( n ?=?17),

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 19, 2019

Uruguay made history by becoming the first country to legalise cultivation, trade and usage of marijuana in December 2013. It has also been found to be at least somewhat effective in the treatment of a handful of sexually transmitted diseases, including Herpes and Chlamydia. Underlining supplied for emphasis).

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Canna Law Blog

NOVEMBER 27, 2021

Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. MDMA (Ecstasy) Nears FDA Approval for PTSD Treatment.

Therapy 95

Therapy Clinical Trials DEA Microdosing 95

Cannabis Law Report

MAY 19, 2022

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. In 2013, section C and J of Canada’s FDR statute were amended so that “restricted drugs” were inaccessible through SAP.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

JUNE 11, 2019

First, the court distinguished between treatments which “serve the sole function of making the plaintiff’s life more bearable or enjoyable” and those that are “reasonably necessary to preserve the plaintiff’s health” 31 Only the latter are compensable. In rejecting the claim, the court cited Torchia v.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. In 2015, Cannabase.io

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

It was fast tracked through the approval process in response to parents of severely epileptic children pushing for a way to legally use CBD, after seeing it work wonders for children profiled in a 2013 CNN documentary called Weed , hosted by Dr. Sanjay Gupta.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

NORML

JANUARY 28, 2019

A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. Nearly 80 percent of Kentuckians support medical marijuana.,

Data 189

Data Clinical Trials Chronic Pain Medicine 189

Cannabis Law Report

JUNE 30, 2019

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. The panel also took up a bill sponsored by Rep. Medical / Health.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40